Pelicci PG - Search Results

1

BLUEPRINT to decode the epigenetic signature written in blood.

Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, Bock C, Boehm B, Campo E, Caricasole A, Dahl F, Dermitzakis ET, Enver T, Esteller M, Estivill X, Ferguson-Smith A, Fitzgibbon J, Flicek P, Giehl C, Graf T, Grosveld F, Guigo R, Gut I, Helin K, Jarvius J, Küppers R, Lehrach H, Lengauer T, Lernmark Å, Leslie D, Loeffler M, Macintyre E, Mai A, Martens JH, Minucci S, Ouwehand WH, Pelicci PG, Pendeville H, Porse B, Rakyan V, Reik W, Schrappe M, Schübeler D, Seifert M, Siebert R, Simmons D, Soranzo N, Spicuglia S, Stratton M, Stunnenberg HG, Tanay A, Torrents D, Valencia A, Vellenga E, Vingron M, Walter J, Willcocks S. Adams D, et al. Among authors: pelicci pg. Nat Biotechnol. 2012 Mar 7;30(3):224-6. doi: 10.1038/nbt.2153. Nat Biotechnol. 2012. PMID: 22398613 No abstract available.

2

Retinoid receptors in health and disease: co-regulators and the chromatin connection.

Minucci S, Pelicci PG. Minucci S, et al. Among authors: pelicci pg. Semin Cell Dev Biol. 1999 Apr;10(2):215-25. doi: 10.1006/scdb.1999.0303. Semin Cell Dev Biol. 1999. PMID: 10441075 Review.

3

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway.

Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, Altucci L, Nervi C, Minucci S, Pelicci PG. Insinga A, et al. Among authors: pelicci pg. Nat Med. 2005 Jan;11(1):71-6. doi: 10.1038/nm1160. Epub 2004 Dec 26. Nat Med. 2005. PMID: 15619634 Free article.

4

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Minucci S, Pelicci PG. Minucci S, et al. Among authors: pelicci pg. Nat Rev Cancer. 2006 Jan;6(1):38-51. doi: 10.1038/nrc1779. Nat Rev Cancer. 2006. PMID: 16397526 Free article. Review.

5

Determinants of oncogenic transformation in acute promyelocytic leukemia: the hetero-union makes the force.

Minucci S, Pelicci PG. Minucci S, et al. Among authors: pelicci pg. Cancer Cell. 2007 Jul;12(1):1-3. doi: 10.1016/j.ccr.2007.06.012. Cancer Cell. 2007. PMID: 17613430 Free article. Review.

6

Histone deacetylases and epigenetic therapies of hematological malignancies.

Mercurio C, Minucci S, Pelicci PG. Mercurio C, et al. Among authors: pelicci pg. Pharmacol Res. 2010 Jul;62(1):18-34. doi: 10.1016/j.phrs.2010.02.010. Epub 2010 Feb 26. Pharmacol Res. 2010. PMID: 20219679 Review.

7

Shiftworking keeps locked-down lab on track.

Natoli G, Minucci S, Pelicci PG. Natoli G, et al. Among authors: pelicci pg. Nature. 2020 Apr;580(7805):590. doi: 10.1038/d41586-020-01268-x. Nature. 2020. PMID: 32346143 No abstract available.

8

The APL-associated fusion proteins.

Minucci S, Cioce M, Maccarana M, Pelicci PG. Minucci S, et al. Among authors: pelicci pg. Haematologica. 1999 Jun;84 Suppl EHA-4:70-1. Haematologica. 1999. PMID: 10907473 Review. No abstract available.

9

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.

Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG. Pearson M, et al. Among authors: pelicci pg. Nature. 2000 Jul 13;406(6792):207-10. doi: 10.1038/35018127. Nature. 2000. PMID: 10910364

10

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

Minucci S, Nervi C, Lo Coco F, Pelicci PG. Minucci S, et al. Among authors: pelicci pg. Oncogene. 2001 May 28;20(24):3110-5. doi: 10.1038/sj.onc.1204336. Oncogene. 2001. PMID: 11420727 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters